Stratagene, Invitrogen Argue Over Amount Of Supersedeas Bond in Texas Court Case | GenomeWeb
Stratagene and Invitrogen last week filed motions in a Texas court arguing over the amount of a supersedeas bond Stratagene intends to post in order to secure a $16.2-million judgment against the firm in a patent suit filed by Invitrogen.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.